RESEARCH INTERESTS...
Purpose: This page provides a summary of my academic research interests.
I completed a PhD with Noreen Murray
at the Institute for Cell and Molecular Biology (now ICB)
at Edinburgh University looking at the
DNA specificity of restriction and
modification systems of bacteria. This work exploited the powerful
genetics of lambda and E.
coli
to determine DNA specificities
of novel restriction enzymes and illuminate the mechanisms of evolution and
adaptation for these enzymes.
Subsequently I moved to the MRC Human
Genetics Unit (and later Medical
Genetics Section, Edinburgh University) with David Porteous studying
gene
therapy for Cystic Fibrosis. My project involved designing and
developing new assays that sensitively measure gene therapy in
clinical trials. From 1999-2002 I pursued a CF-trust award to explore the
possibility of using DNA repair as a therapy for
Cystic Fibrosis. This
project was focused upon manipulating the
mechanisms of DNA repair (and more
specifically homologous recombination) in mammalian cells.
This work became part of the UK CF gene therapy
consortium.
In 2002 I moved to the department of Genetics &
Development at Columbia
University (New York) to work with Rodney
Rothstein's group on the mechanisms of homologous recombination. Our
work
focuses upon the genes and proteins that are responsible for this
process and their role in determining the recombination status of
different cells.

Publications links to articles are provided in some cases - click on the journal title.
Thorpe, P.H. 1995. Ph.D Thesis. Institute of Cell and Molecular Biology, Edinburgh University, UK. The DNA Specificity of Type I Restriction and Modification Enzymes.
Dryden, D.T.F. Cooper, L.P. Thorpe, P.H. and Byron, O. 1997. The in vitro assembly of the EcoKI type I DNA restriction/modification enzyme and its in vivo implications. Biochemistry. 36. 1065-1076.
Thorpe, P.H. Ternent, D. and Murray, N.E. 1997. The Specificity of StySKI, a type I restriction enzyme, implies a structure with rotational symmetry. Nucleic Acids Research. 25. 1694-1700.
Thorpe, P.H. and Porteous, D.J. 1999. Rapid quantitation of gene therapy specific CFTR expression using the Amplification Refractory Mutation System. Biotechniques. 27 (1);122-127.
Thorpe, P.H. Stevenson, B.J. and Porteous D.J. 2002. Functional correction of episomal mutations with short DNA fragments and RNA-DNA oligonucleotides. J. Gene Medicine 4; 195-204.
Thorpe, P. Stevenson, B.J. and Porteous D.J. 2002. Optimising gene repair strategies in cell culture. Gene Therapy 9; 700-702.
Simpson, A.J. King, J.A. Thorpe, P.H. McLachlan, G. and Sallenave, J-M. 2004. Towards gene therapy for inflammatory and infective pulmonary diseases. Current Genomics. 5; 365-383.
Thorpe, P.H. Marrero, V.A. Savitzky, M.H. Sunjevaric, I. Freeman, T.C. and Rothstein, R. 2006. Cells expressing murine RAD52 splice variants favor sister chromatid repair. Mol. Cell Biol. 26; 3752-3763.
Cagney, G. Alvaro, D. Reid, R.J. Thorpe, P.H. Rothstein, R. and Krogan, N.J. 2006. Functional genomics of the yeast DNA-damage response. Genome Biol. 7.
Thorpe, P.H. González-Barrera, S. and Rothstein, R. 2007. More
is not
always better: the genetic constraints of polyploidy. Trends in Genetics
6; 263-266.
Thorpe, P.H.; McLachlan, G.; Davidson-Smith, H.; Stevenson, B.J.; and Porteous, D.J. 1998. Sensitive assays to monitor the efficiency of delivery and expression of gene therapy vectors for cystic fibrosis. Pediatric Pulmonology S17; (253) p.271.
Thorpe, P.H.; Stevenson,B.J.; Gohil, A; and Porteous, D.J. 2000. Towards CFTR Gene Correction: A Comparison of two key strategies. Pediatric Pulmonology S20; (244) p.241.
Thorpe, P.H.; Stevenson, B.J.; and Porteous, D.J. 2001. Comparing two strategies for functional gene correction. Mol. Ther. 3;1143 p.S401.
Thorpe, P.H.; Stevenson, B.J.; and Porteous D.J. 2002. Analysing Mammalian Gene Repair Using GFP. Mol. Ther. 5;402 p.S132.
Disclaimer: The information provided on these pages is not
guaranteed to
be accurate, I would appreciate if you would e-mail me if
you find any mistakes. Any views expressed are entirely my own and do not
necessarily
reflect
those of my employers or other Columbia University
staff/students.
Last updated December 07